Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

LRRC75A/FAM211A anticorps (AA 52-292) (Cy3)

L’anticorps anti-LRRC75A/FAM211A Polyclonal Lapin est utilisé pour la détection de LRRC75A/FAM211A dans des échantillons de Humain. Il a été validé pour FACS.
N° du produit ABIN8005557
720,50 €
Plus frais de livraison 40,00 € et TVA
100 μg
Destination: France
Envoi sous 8 à 12 jours ouvrables

Aperçu rapide pour LRRC75A/FAM211A anticorps (AA 52-292) (Cy3) (ABIN8005557)

Antigène

LRRC75A/FAM211A (LRRC75A) (Leucine Rich Repeat Containing 75A (LRRC75A))

Reactivité

Humain

Hôte

  • 13
Lapin

Clonalité

  • 13
Polyclonal

Conjugué

  • 4
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp LRRC75A/FAM211A est conjugé à/à la Cy3

Application

  • 10
  • 6
  • 5
  • 2
Flow Cytometry (FACS)
  • Épitope

    • 12
    • 1
    AA 52-292

    Fonction

    Anti-LRRC75A Antibody Cy3 Conjugated

    Réactivité croisée (Details)

    No cross reactivity with other proteins.

    Purification

    Immunogen affinity purified.

    Immunogène

    E.coli-derived human LRRC75A recombinant protein (Position: H52-Q292).

    Isotype

    IgG
  • Indications d'application

    Flow Cytometry, 1-3 μg/1x106 cells

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    Each vial contains 50 % glycerol, 0.9 % NaCl, 0.2 % Na2HPO4, 0.02 % Sodium azide.

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    -20 °C

    Stockage commentaire

    At -20°C for one year from date of receipt. Avoid repeated freezing and thawing. Protect from light.

    Date de péremption

    12 months
  • Antigène

    LRRC75A/FAM211A (LRRC75A) (Leucine Rich Repeat Containing 75A (LRRC75A))

    Autre désignation

    LRRC75A

    Sujet

    Background: Long noncoding RNAs (lncRNAs) play multiple key roles during inflammatory processes. A novel lncRNA identified by the high-throughput sequencing analysis was found significantly down-regulated in Escherichia coli-introduced cell model of bovine mastitis. Given that this lncRNA consists of the antisense of leucine-rich repeat-containing protein 75A (LRRC75A), it was named LRRC75A antisense lncRNA1 (LRRC75A-AS1). The expression of LRRC75A-AS1 was down-regulated in bovine mammary epithelial cells and mammary tissues under inflammatory condition. Knockout (KO) of LRRC75A-AS1 by CRISPR-Cas9 system in bovine mammary alveolar cell-T (MAC-T) cell line could enhance expressions of tight junction (TJ) proteins Claudin-1, Occludin and ZO-1, reduce cell monolayer permeability, and inhibit Staphylococcus aureus adhesion and invasion. Meanwhile, it also down-regulated expressions of inflammatory factors and attenuated activation of NF-κB pathway. Similarly, knockdown of LRRC75A caused the changes as LRRC75A-AS1 KO did, while overexpression of LRRC75A enabled the opposite effects. TJ of epithelioid cells barriers the pathogenic microorganisms outside during inflammation, in which LRRC75A-AS1 can regulate the expression of TJ proteins through LRRC75A, affecting the development of inflammation.

    Gene Full Name: leucine rich repeat containing 75A

    ID gène

    388341

    UniProt

    Q8NAA5
Vous êtes ici:
Chat with us!